NCT04600284View on ClinicalTrials.gov

Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

January 20, 2021

Study Completion Date

April 30, 2021

Conditions
Hypertension
Interventions
DRUG

AD-2101

AD-2101 16/5mg

DRUG

AD-2102

AD-2102 25mg

DRUG

AD-2101 + AD-2102

AD-2101 16/5mg + AD-2102 25mg

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Addpharma Inc.

INDUSTRY

NCT04600284 - Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102 | Biotech Hunter | Biotech Hunter